Feedback / Questions
berubicin (RTA 744) - CNS Pharma, WPD Pharma
https://www.prnewswire.com/news-releases/cns-announces-the-fda-has-granted-orphan-drug-designation-for-brain-cancer-drug-berubicin-301074249.html
Jun 11, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next